NewGenIvf Group Limited (NASDAQ:NIVF) Short Interest Update

NewGenIvf Group Limited (NASDAQ:NIVF) was the target of a significant growth in short interest in the month of February. As of February 27th, there was short interest totaling 19,795 shares, a growth of 80.4% from the February 12th total of 10,974 shares. Based on an average daily trading volume, of 71,938 shares, the short-interest ratio is presently 0.3 days. Currently, 3.0% of the shares of the company are sold short. Currently, 3.0% of the shares of the company are sold short. Based on an average daily trading volume, of 71,938 shares, the short-interest ratio is presently 0.3 days.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on the company. Weiss Ratings restated a “sell (d)” rating on shares of NewGenIvf Group in a research report on Wednesday, January 28th. Wall Street Zen raised NewGenIvf Group to a “hold” rating in a research report on Saturday, December 6th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock currently has an average rating of “Sell”.

NewGenIvf Group Stock Up 14.0%

NASDAQ NIVF opened at $0.57 on Friday. The company has a debt-to-equity ratio of 0.17, a current ratio of 3.43 and a quick ratio of 3.37. NewGenIvf Group has a 52-week low of $0.45 and a 52-week high of $1,110.00. The firm has a 50-day moving average price of $1.13 and a 200 day moving average price of $10.51.

Shares of NewGenIvf Group are set to reverse split before the market opens on Monday, March 16th. The 1-4 reverse split was recently announced. The number of shares owned by shareholders will be adjusted after the closing bell on Sunday, March 15th.

NewGenIvf Group Company Profile

NewGenIVF Group Inc, trading on NASDAQ under the symbol NIVF, is an integrated provider of reproductive medicine services in the People’s Republic of China. The company operates a network of fertility clinics across major Chinese cities, delivering comprehensive infertility diagnosis and treatment to patients and couples. Its facilities are equipped with modern laboratories and surgical suites designed for assisted reproductive procedures.

NewGenIVF’s service offerings encompass a wide range of assisted reproductive technologies (ART), including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and fertility preservation through ovarian tissue and gamete cryopreservation.